The specialty chemicals sector has faced headwinds over the past year, but Q4 FY25 shows signs of stabilisation ...

Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...

US pharma giants eye India’s obesity crisis with pricey shots, sparking ‘Make in India’ and affordability debates ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

AARISE PHARMACEUTICALS, HARIDWAR (UK) is a fast-growing pharmaceutical company that has made a strong impact in the ...

Starting at Rs 3,500 per injection, with a monthly cost of up to Rs 14,000, Mounjaro enters India’s growing diabetes and ...

Introduction of a direct-to-patient delivery model for its weight-loss drug in the United States could potentially delay its ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

US giant, Eli Lilly launched Mounjaro (tirzepatide) which is a prescription medicine for adults with type 2 diabetes used ...

However, much to India’s benefit, geopolitical tensions, trade restrictions, and COVID-related disruptions led pharma ...

Eli Lillys famous weight loss drug will now be sold in India after the drug maker received approval from CDSCO. What are its ...